News Room

All Press Releases In The News Blogs
11 Dec 2017
Press Release
Minerva Neurosciences Names Richard Russell President 
Minerva Neurosciences (NASDAQ: NERV)
11 Dec 2017
Press Release
Minerva Neurosciences Elects William Doyle and Hans Peter Hasler to Board of Directors 
Minerva Neurosciences (NASDAQ: NERV)
06 Dec 2017
Press Release
Minerva Neurosciences Announces Enrollment of First Patient in Phase 2b Trial of Seltorexant (MIN-202) in Patients With Insomnia Disorder 
Minerva Neurosciences (NASDAQ: NERV)
05 Dec 2017
Press Release
ObsEva Initiates PROLONG, the Phase 2a Clinical Trial of OBE022 in Preterm Labor 
ObsEva (NASDAQ: OBSV)
05 Dec 2017
Press Release
GenSight Biologics reports positive long-term visual acuity gains and safety results from Phase I/II Study of GS010 for the treatment of Leber Hereditary Optic Neuropathy (LHON) 
Gensight (Euronext: SIGHT)
30 Nov 2017
In The News
Bloomberg
The Bloomberg 50 - From finance and politics to tech and entertainment, these people defined global business in 2017 
28 Nov 2017
Press Release
Egalet Announces Positive Top-Line Results from Phase 3 Study Evaluating Efficacy and Safety of Egalet-002 in Patients with Moderate-to-Severe Chronic Low Back Pain 
Egalet (NASDAQ:EGLT)
20 Nov 2017
Press Release
Egalet Received a Grant from InnoBooster to Develop a Novel Application of Guardian™ Technology 
Egalet (NASDAQ:EGLT)
16 Nov 2017
Press Release
Egalet Announces Positive Top-Line Results from Phase 3 Safety Study Evaluating Safety of Egalet-002 
Egalet (NASDAQ:EGLT)
09 Nov 2017
Press Release
Molecular Partners expands and advances robust pipeline of DARPin® therapies in oncology and ophthalmology 
Molecular Partners (S​wiss​: MOLN.SW)
07 Nov 2017
Press Release
ObsEva SA Announces the Completion of Patient Recruitment in the EDELWEISS Phase 2b Clinical Trial of OBE2109 for the Treatment of Endometriosis 
ObsEva (NASDAQ: OBSV)
06 Nov 2017
Press Release
Egalet Announces ARYMO ER Added to Large Payer Medicare Part D Formulary 
Egalet (NASDAQ:EGLT)
01 Nov 2017
Press Release
Palladio Biosciences Announces Presentations of New Data for Lixivaptan and Polycystic Kidney Disease during the American Society of Nephrology 2017 Annual Meeting 
Palladio Biosciences - Centessa Therapeutics (NASDAQ:CNTA)
31 Oct 2017
Press Release
Shareholders of Molecular Partners approved the elections of Bill Burns and Patrick Amstutz to the Board of Directors 
Molecular Partners (S​wiss​: MOLN.SW)
31 Oct 2017
Press Release
Minerva Neurosciences Names Dr. Justine Lalonde as Senior Vice President, Product Strategy 
Minerva Neurosciences (NASDAQ: NERV)
26 Oct 2017
Press Release
Versartis Hires Cowen to Assist in Evaluating Potential Strategic Transactions 
Versartis (NASDAQ: VSAR)
26 Oct 2017
Press Release
GenSight Biologics Reports its Cash Position as of September 30, 2017 
Gensight (Euronext: SIGHT)
25 Oct 2017
Press Release
GenSight Biologics Appoints Barrett Katz as Chief Medical Officer 
Gensight (Euronext: SIGHT)
13 Oct 2017
Press Release
Startup Impact Biomedicines Raises $22M to Bring Fedratinib to Myelofibrosis Patients 
Impact Biomedicines - (NYSE: BMY)
12 Oct 2017
Press Release
First patient dosed in phase 1 clinical study of Molecular Partners’ second proprietary oncology asset MP0274 
Molecular Partners (S​wiss​: MOLN.SW)
12 Oct 2017
In The News
Business Wire
Gadeta Strengthens Executive Management Team with the Appointments of Shelley Margetson as CEO & Thomas Davis as CMO 
11 Oct 2017
Press Release
University of Toronto and Medicxi launch Janpix Inc. with US $19M in funding to advance Dual Impact Cancer Therapies 
Janpix - Centessa Therapeutics (NASDAQ:CNTA)
10 Oct 2017
Press Release
ObsEva SA Announces $60.0 Million Private Placement with Existing and New Investors 
ObsEva (NASDAQ: OBSV)
04 Oct 2017
Press Release
Palladio Biosciences Receives Orphan Drug Designation from the U.S. FDA for Lixivaptan for the Treatment of Autosomal Dominant Polycystic Kidney Disease 
Palladio Biosciences - Centessa Therapeutics (NASDAQ:CNTA)
03 Oct 2017
Press Release
Bill Burns nominated for election to Molecular Partners’ Board of Directors as Vice-Chairman with nomination to Chairman in 2018 
Molecular Partners (S​wiss​: MOLN.SW)
02 Oct 2017
Press Release
GenSight Biologics integrates the Enternext® PEA-PME 150 index 
Gensight (Euronext: SIGHT)
21 Sep 2017
Press Release
Versartis Announces Phase 3 VELOCITY Trial of Somavaratan in Pediatric Growth Hormone Deficiency Did Not Meet Primary Endpoint 
Versartis (NASDAQ: VSAR)
19 Sep 2017
Press Release
GenSight Biologics integrates the CAC® Small, CAC® Mid and Small and CAC® All-Tradable Euronext indexes 
Gensight (Euronext: SIGHT)
19 Sep 2017
Press Release
Moncef Slaoui joins Medicxi
18 Sep 2017
Press Release
National Lacrosse League and Egalet Corporation Announce Educational Partnership Around A Non-Narcotic Pain Option and Responsible Pain Management 
Egalet (NASDAQ:EGLT)
14 Sep 2017
In The News
B3C Newswire
Levicept Starts First-in-Human Phase I Trial of LEVI-04, A Novel Fusion Protein Therapy for Chronic Pain 
14 Sep 2017
In The News
Kent Online
Joint-pain treatment set for human trials after development by Levicept in Discovery Park in Sandwich 
14 Sep 2017
Press Release
Levicept Starts First-in-Human Phase I Trial of LEVI-04, A Novel Fusion Protein Therapy for Chronic Pain 
Levicept
11 Sep 2017
Press Release
Minerva Neurosciences Names Dr. Jay Saoud as Senior Vice President, Head of Research and Development 
Minerva Neurosciences (NASDAQ: NERV)
10 Sep 2017
In The News
Le Temps
«Les Suisses se méfient encore du capital-risque» 
08 Sep 2017
Press Release
Egalet Presented New Data at PAINWEEK Demonstrating Potential of ARYMO ER to Deter Opioid Abuse 
Egalet (NASDAQ:EGLT)
06 Sep 2017
Press Release
ObsEva SA Announces the Completion of Patient Recruitment in the IMPLANT2 Phase 3 Clinical Trial in Assisted Reproductive Technology Ahead of Schedule 
ObsEva (NASDAQ: OBSV)
05 Sep 2017
Press Release
Versartis Announces Expansion of Executive Leadership Team with Addition of Dr. Robert Gut as the Head of Global Clinical, Medical and Regulatory Affairs 
Versartis (NASDAQ: VSAR)
05 Sep 2017
Press Release
Minerva Neurosciences Announces Enrollment of First Patient in Phase 2b Trial of Seltorexant (MIN-202) as Adjunctive Therapy in Patients With Major Depressive Disorder 
Minerva Neurosciences (NASDAQ: NERV)
05 Sep 2017
Press Release
Egalet's Partner Ascend Therapeutics® U.S., LLC Begins Promotion of SPRIX® Nasal Spray 
Egalet (NASDAQ:EGLT)
04 Sep 2017
In The News
Labiotech.eu
Meet this Blockbuster Developer turned Partner at a Headlining VC 
30 Aug 2017
Press Release
Molecular Partners reports key financials and corporate highlights for H1 2017: Pipeline development on track with several key milestones ahead 
Molecular Partners (S​wiss​: MOLN.SW)
25 Aug 2017
Press Release
Minerva Neurosciences Announces European Commission Approval of Amendment of MIN-202 Agreement With Janssen 
Minerva Neurosciences (NASDAQ: NERV)
01 Aug 2017
Press Release
GenSight Biologics Completes Enrollment of RESCUE Phase III Study of GS010 in the treatment of Leber’s Hereditary Optic Neuropathy 
Gensight (Euronext: SIGHT)
05 Jul 2017
Press Release
Diasome Pharmaceuticals, Inc. Receives Funding From JDRF T1D Fund 
Diasome
05 Jul 2017
In The News
BioCentury Innovations
Diasome Raises $30M in Series A Round 
05 Jul 2017
In The News
Business Wire
Diasome Pharmaceuticals, Inc. Receives Funding Led By Medicxi 
23 Jun 2017
Press Release
GenSight Biologics successfully raises €22.5 million from leading investors in the US and Europe 
Gensight (Euronext: SIGHT)
22 Jun 2017
Press Release
Minerva Announces Completion of Bridging Study to Select Improved Formulation of MIN-101 for Use in Phase 3 Trial for the Treatment of Negative Symptoms in Patients With Schizophrenia 
Minerva Neurosciences (NASDAQ: NERV)
20 Jun 2017
Press Release
Egalet Receives Complete Response Letter from U.S. Food and Drug Administration for Prior Approval Supplement for 10 mg and 15 mg Dosage Strengths of OXAYDO 
Egalet (NASDAQ:EGLT)
15 Jun 2017
Press Release
Medicxi launches first $300m late-stage life sciences fund Medicxi Growth 1 (MG1), backed by Novartis and Verily
15 Jun 2017
Blog
Introducing Medicxi Growth 1, Our First $300m Late-Stage Fund
by Giuseppe Zocco
14 Jun 2017
Press Release
GenSight Biologics reports long-term positive safety and visual acuity results at Week 96 in Phase I/II Study of GS010 for the treatment of Leber’s Hereditary Optic Neuropathy (LHON) 
Gensight (Euronext: SIGHT)
07 Jun 2017
Press Release
ObsEva SA Announces the Completion of a Phase 1 PK/PD Clinical Trial Evaluating Different Doses of OBE2109 and Add-Back Therapy 
ObsEva (NASDAQ: OBSV)
07 Jun 2017
Press Release
Egalet Partners with Ascend Therapeutics® U.S., LLC to Co-Promote SPRIX® Nasal Spray 
Egalet (NASDAQ:EGLT)
30 May 2017
Press Release
Molecular Partners provides additional details on clinical studies of proprietary lead oncology asset MP0250 
Molecular Partners (S​wiss​: MOLN.SW)
23 May 2017
Press Release
Palladio Biosciences Formed to Develop Transformative Medicines for Orphan Diseases of the Kidney 
Palladio Biosciences - Centessa Therapeutics (NASDAQ:CNTA)
22 May 2017
Press Release
Versartis Presents 3-Year Somavaratan Safety and Efficacy Data and Pediatric Program Baseline Demographics at the 19th European Congress of Endocrinology 
Versartis (NASDAQ: VSAR)
18 May 2017
Press Release
ObsEva Announces the Completion of a Phase 1 Drug-Drug Interaction Study with OBE022 
ObsEva (NASDAQ: OBSV)
18 May 2017
Press Release
ObsEva Reports First Quarter 2017 Financial Results and Business Update 
ObsEva (NASDAQ: OBSV)
18 May 2017
Press Release
Egalet Announces Results of ARYMO® ER Harm Reduction Modeling Analysis 
Egalet (NASDAQ:EGLT)
17 May 2017
Press Release
Egalet Announces ARYMO™ ER Data Published in Journal of Opioid Management and American Journal of Drug and Alcohol Abuse 
Egalet (NASDAQ:EGLT)
15 May 2017
Press Release
Egalet Announces Scientific Presentations at American Pain Society Meeting 
Egalet (NASDAQ:EGLT)
15 May 2017
Press Release
Minerva Announces Outcome of End-of-Phase 2 Meeting With FDA 
Minerva Neurosciences (NASDAQ: NERV)
15 May 2017
Press Release
Minerva Provides Update on Phase 3 Design and Development Strategy for MIN-101 
Minerva Neurosciences (NASDAQ: NERV)
12 May 2017
Press Release
Patrick Amstutz Appointed as Chief Executive Officer 
Molecular Partners (S​wiss​: MOLN.SW)
11 May 2017
Press Release
Panel of Leading Pain Management Specialists Highlight Potential Role of Abuse-Deterrent Formulations of Opioids and Non-Narcotics to Help Curb Misuse and Abuse at Egalet Investor Day 
Egalet (NASDAQ:EGLT)
10 May 2017
Press Release
Egalet Reports First Quarter 2017 Financial Results 
Egalet (NASDAQ:EGLT)
09 May 2017
Press Release
Molecular Partners’ strategic partner Allergan completed patient recruitment in both abicipar pegol nAMD Phase 3 studies 
Molecular Partners (S​wiss​: MOLN.SW)
08 May 2017
Press Release
GenSight Biologics to Present Data on GS010 and GS030 at the Annual Meeting of ARVO 
Gensight (Euronext: SIGHT)
04 May 2017
Press Release
Minerva Neurosciences Reports First Quarter 2017 Financial Results and Business Updates 
Minerva Neurosciences (NASDAQ: NERV)
03 May 2017
Press Release
Spin-out Z Factor announces £7 million Series A funding to bring lung treatment to the clinic 
Z Factor - Centessa Therapeutics (NASDAQ:CNTA)
03 May 2017
Press Release
Acutus Medical® Receives FDA Clearance for AcQGuideTM Steerable Sheath 
Acutus Medical
03 May 2017
Press Release
GenSight Biologics Appoints Mohamed Genead as Chief Medical Officer 
Gensight (Euronext: SIGHT)
28 Apr 2017
Press Release
GenSight Biologics Announces the Filing of its 2016 Registration Document 
Gensight (Euronext: SIGHT)
27 Apr 2017
Press Release
Acutus Medical® Announces Completion of Enrollment for UNCOVER AF™ Study of AcQMap® in Persistent Atrial Fibrillation 
Acutus Medical
27 Apr 2017
Press Release
Versartis Reports First Quarter 2017 Financial Results 
Versartis (NASDAQ: VSAR)
27 Apr 2017
Press Release
GenSight Biologics to Present GS010 at the 4th Annual Retinal Cell & Gene Therapy Innovation Summit 
Gensight (Euronext: SIGHT)
27 Apr 2017
Press Release
Minerva Neurosciences to Report First Quarter 2017 Financial Results and Business Updates on May 4, 2017 
Minerva Neurosciences (NASDAQ: NERV)
26 Apr 2017
Press Release
Egalet to Report First Quarter 2017 Financial Results During Investor Day on May 10, 2017 in New York 
Egalet (NASDAQ:EGLT)
25 Apr 2017
Press Release
ObsEva SA Initiates Phase 3 Clinical Program for OBE2109 in Uterine Fibroids 
ObsEva (NASDAQ: OBSV)
25 Apr 2017
Press Release
Versartis Appoints Jay Stout, Ph.D., as Senior Vice President, Technical Operations 
Versartis (NASDAQ: VSAR)
20 Apr 2017
Press Release
GenSight Biologics to Present GS010 at the 2017 Annual Meeting of the American Academy of Neurology 
Gensight (Euronext: SIGHT)
18 Apr 2017
Press Release
Egalet Announces U.S. Food and Drug Administration Acceptance of File for Prior Approval Supplement for OXAYDO® (oxycodone HCl, USP) tablets C-II 10 mg and 15 mg Dosage Strengths 
Egalet (NASDAQ:EGLT)
12 Apr 2017
Press Release
Christian Zahnd appointed as Honorary Chairman of the Board of Directors as he decided not to stand for re-election as member of the Board of Directors at the Annual General Meeting 2017 
Molecular Partners (S​wiss​: MOLN.SW)
10 Apr 2017
Press Release
Egalet Corporation Announces Changes to Board of Directors 
Egalet (NASDAQ:EGLT)
03 Apr 2017
Press Release
Versartis Reports New Data on Long-Acting Somavaratan in Growth Hormone Deficiency at ENDO 2017 
Versartis (NASDAQ: VSAR)
03 Apr 2017
Press Release
Versartis Announces Three Year Somavaratan Data at ENDO 2017 Showing Safety and Efficacy in Line with Historical U.S. Daily rhGH Data in Pediatric GHD 
Versartis (NASDAQ: VSAR)
01 Apr 2017
In The News
Nature Biotech
Gadeta: extending the reach of CAR T cells 
31 Mar 2017
Press Release
Molecular Partners Publishes Audited Financial Results and Annual Report 2016 
Molecular Partners (S​wiss​: MOLN.SW)
29 Mar 2017
Press Release
Egalet Announces U.S. Food and Drug Administration Does Not Object to Egalet's Distribution of Materials and Communications to Healthcare Professionals Regarding Abuse-Deterrent Properties of ARYMO™ ER via Intranasal Route 
Egalet (NASDAQ:EGLT)
23 Mar 2017
Press Release
SuperX Awarded Cambridge Torchbearer Award at 2017 Business Weekly Annual Awards Dinner 
SuperX
21 Mar 2017
Press Release
Minerva Neurosciences Announces Recent Exercise of Warrants by Institutional Stockholders and Open Market Purchase of Common Stock by Chairman of Its Board of Directors 
Minerva Neurosciences (NASDAQ: NERV)
17 Mar 2017
Press Release
ObsEva to Present Pharmacology Results Demonstrating OBE022 Exerts a Synergistic Effect in Combination with Standard of Care in Animal Model for Preterm Labor 
ObsEva (NASDAQ: OBSV)
15 Mar 2017
Press Release
Versartis Appoints Tracy Woody as Chief Commercial Officer 
Versartis (NASDAQ: VSAR)
13 Mar 2017
Press Release
GenSight Biologics Reports Full Year 2016 Financial Results 
Gensight (Euronext: SIGHT)
13 Mar 2017
Press Release
Minerva Neurosciences Reports Fiscal 2016 Fourth Quarter and Year End Financial Results and Business Updates 
Minerva Neurosciences (NASDAQ: NERV)
09 Mar 2017
Press Release
Egalet Reports Fourth Quarter and Full Year 2016 Financial Results 
Egalet (NASDAQ:EGLT)
07 Mar 2017
Press Release
ObsEva Starts Phase 3 Clinical Program for Nolasiban in ART 
ObsEva (NASDAQ: OBSV)
06 Mar 2017
Press Release
Minerva Neurosciences to Report Fiscal 2016 Fourth Quarter and Year End Financial Results and Business Updates on March 13, 2017 
Minerva Neurosciences (NASDAQ: NERV)